Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer



Status:Completed
Conditions:Cancer, Cancer, Pancreatic Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/23/2018
Start Date:September 2008
End Date:July 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Unresectable Pancreatic Cancer

This study will evaluate the local control rate as well as acute and late toxicity rates of
stereotactic body radiotherapy (SBRT) for the treatment of unresectable pancreatic cancer.

This is a single institution, non-randomized, prospective, phase IV trial of SBRT for
unresectable pancreatic cancer.

Data collected will include patient demographics, pathology data, tumor stage, SBRT dose
fractionation scheme, dose received by adjacent critical normal tissues, tumor recurrence
data, and acute and late toxicities.

Follow up data will be collected during the patient's standard office visits. The anticipated
duration of this study is 5 years.

Inclusion Criteria:

- Patient age >= 18 years

- Performance status of 0-3

- Unresectable pancreatic cancer

- Maximum tumor diameter < 7.5 cm

- Signed study-specific consent form

Exclusion Criteria:

- Maximum tumor diameter > 7.5 cm

- Prior radiotherapy to the upper abdomen

- Pregnant or lactating women, due to potential exposure of the fetus to RT and unknown
effects of RT on lactating females

- Patients with psychiatric or addictive disorder that would preclude obtaining informed
consent
We found this trial at
1
site
St John's Mercy Medical Center
621 South New Ballas Road
Saint Louis, Missouri 63141
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials